Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002027 · ClinicalTrials.gov registry record · NA
Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
A NA study, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00002027 is a NA study that has completed, run by Janssen. The registered enrollment target is 60 participants.
The verdict
NCT00002027, a NA study, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of side effects as reported by patients at their visits and by frequent monitoring of hematology, biochemistries, and urinalysis.
Interventions
- DRUG Diclazuril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002027
The ClinicalTrials.gov registry entry for NCT00002027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diclazuril is the first listed.
NCT00002027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002027 about?
NCT00002027 is a clinical study titled "Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)". To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of...
What is the current status of trial NCT00002027?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants.
What interventions are being tested in trial NCT00002027?
The interventions under investigation include: Diclazuril (DRUG).
Who is sponsoring clinical trial NCT00002027?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.